Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ignore the Market on Apple Inc. (AAPL)

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case they’re material to our investing thesis.

The current month of September appears to be firmly intent on challenging its historical record with regard to stocks, with yet another up day in the books — the seventh in a row. That’s right, stocks have so far risen every day this month. Today, the S&P 500 (INDEXSP:.INX) added another .3%, while the narrower, price-weighted Dow Jones Industrial Average (INDEXDJX:.DJI) was up 0.9%.

With that winning streak in mind, it’s not surprising that the VOLATILITY S&P 500 (INDEXCBOE:VIX) fell another 4.9% today, to close at 13.82 — the VIX, Wall Street’s “fear index,” is calculated from S&P 500 option prices and reflects investor expectations for stock market volatility over the coming 30 days. The VIX has now fallen nearly 19% since the beginning of the month.

Apple Inc. (NASDAQ:AAPL)Carl Icahn’s case for Apple
Yesterday, I highlighted investors’ dissatisfaction with Apple Inc. (NASDAQ:AAPL)‘s premium pricing strategy for the lower-end model iPhone 5C it released yesterday. That process continued to play out today, with the shares declining another 5.4%, adding to yesterday’s 2.3% loss.

One highly astute market participant who was unfazed by the decline is billionaire activist investor Carl Icahn, who told CNBC today:

I really think Apple Inc. (NASDAQ:AAPL) is one of my best right now. At these levels, we’re buying quite a bit of stock… We bought quite a bit today in the $465, $470, $467 range, $466… That’s not to say it won’t go any lower — I don’t really look at it from day-to-day and we don’t try to fix what the market is going to do. I think if they do a big buyback, that’s going to be a major plus, but I also think the products are pretty good and I think they’re going to get a lot of business from China and they’re going to do great anyway. You don’t see companies like this with this kind of brand.

Back on August 13, Icahn tweeted that he had amassed had a large position in Apple Inc. (NASDAQ:AAPL) and believed the company “to be extremely undervalued.” Today, he made the case for the stock succinctly:

We look at the markets and look for no-brainers and I think Apple Inc. (NASDAQ:AAPL) is just a no-brainer. It’s extremely cheap — you just look at the numbers on Apple and if you back out cash, you’re really paying less than $300 billion for Apple and its EBIT [Earnings Before Interest and Taxes, a measure of cash flow] is about $50 billion, so your return is 18% or 5.6 times. But the real kicker is that if they do a huge buyback — not even huge, $150 billion — you’re only paying three times EBIT, you’re getting the 33% return. With those numbers in a company that is growing and has a great brand — if somebody offered you that and didn’t tell you the name of it, you’d pay ’em to tell you what the company was.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.